E-LIB Suche - Ergebnisse für: Sette, Angelica

1

Preclinical Characterization and Phase I Trial Results of a..:

Muik, Alexander ; Garralda, Elena ; Altintas, Isil...
Cancer Discovery. 12 (2022) 5 - p. 1248-1265 , 2022

Link: https://doi.org/10.1158/..

2

The multi-specific VH-based Humabody CB213 co-targets PD1 a..:

Edwards, Carolyn J. ; Sette, Angelica ; Cox, Carl...
British Journal of Cancer. 126 (2021) 8 - p. 1168-1177 , 2021

Link: https://doi.org/10.1038/..

3

Generation and characterization of novel recombinant anti-h..:

Duranti, Claudia ; Carraresi, Laura ; Sette, Angelica...
Oncotarget. 9 (2018) 79 - p. 34972-34989 , 2018

Link: https://doi.org/10.18632..

4

Targeting of viral interleukin-10 with an antibody fragment..:

Hughes, Chris ; Sette, Angelica ; Seed, Michael...
Arthritis Research & Therapy. 16 (2014) 4 - p. R151 , 2014

Link: https://doi.org/10.1186/..

5

Development of novel anti-Kv 11.1 antibody-conjugated PEG–T..:

Sette, Angelica ; Spadavecchia, Jolanda ; Landoulsi, Jessem...
Journal of Nanoparticle Research. 15 (2013) 12 - p. , 2013

Link: https://doi.org/10.1007/..

6

Mitochondrial and sarcoplasmic reticulum abnormalities in c..:

Fontes-Oliveira, Cibely Cristine ; Busquets, Sílvia ; Toledo, Míriam...
Biochimica et Biophysica Acta (BBA) - General Subjects. 1830 (2013) 3 - p. 2770-2778 , 2013

Link: https://doi.org/10.1016/..

7

Theophylline is able to partially revert cachexia in tumour..:

Olivan, Mireia ; Springer, Jochen ; Busquets, Sílvia...
Nutrition & Metabolism. 9 (2012) 1 - p. 76 , 2012

Link: https://doi.org/10.1186/..

8

Nutraceutical inhibition of muscle proteolysis: A role of d..:

Olivan, Mireia ; Busquets, Sílvia ; Figueras, Maite...
Clinical Nutrition. 30 (2011) 1 - p. 33-37 , 2011

Link: https://doi.org/10.1016/..

9

Preclinical Characterization and Phase I Trial Results of a..:

Muik, Alexander ; Garralda, Elena ; Altintas, Isil...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662884/. , 2022

Link: http://www.ncbi.nlm.nih...

10

The multi-specific V(H)-based Humabody CB213 co-targets PD1..:

Edwards, Carolyn J ; Sette, Angelica ; Cox, Carl...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023588/. , 2021

Link: http://www.ncbi.nlm.nih...

11

Targeting of viral interleukin-10 with an antibody fragment..:

Hughes, Chris ; Sette, Angelica ; Seed, Michael...
http://arthritis-research.com/content/16/4/R151. , 2014

Link: http://arthritis-researc..

12

Targeting of viral interleukin-10 with an antibody fragment..:

Hughes, Chris ; Sette, Angelica ; Seed, M...
https://repository.uel.ac.uk/download/4fc1ea6937ab7b0f60c6556662c8b55b111cdaf2a54ebb09c8dbcb3def430e31/1952605/ar4613.pdf. , 2014

Link: https://repository.uel.a..

13

Development of novel anti-Kv 11.1 antibody-conjugated PEG-T..:

Sette, Angelica ; Spadavecchia, Jolanda ; Landoulsi, Jessem...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s11051-013-2111-6. , 2013

Link: https://hal.sorbonne-uni..

14

Development of novel anti-Kv 11.1 antibody-conjugated PEG-T..:

Sette, Angelica ; Spadavecchia, Jolanda ; Landoulsi, Jessem...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s11051-013-2111-6. , 2013

Link: https://hal.sorbonne-uni..

15

Development of novel anti-Kv 11.1 antibody-conjugated PEG–T..:

Sette, Angelica ; Spadavecchia, Jolanda ; Landoulsi, Jessem...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857862. , 2013

Link: http://www.ncbi.nlm.nih...